MoneyWorks4Me

Supriya Lifescience submits analyst meet intimation

06 Mar 2024 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company, Supriya Lifescience will be interacting with Analyst/Institutional Investors on 11-03-2024 as per details enclosed. Copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..